Cargando…

The Integration of Cell Therapy and Biomaterials as Treatment Strategies for Remyelination

Multiple sclerosis (MS) is a chronic degenerative autoimmune disease of the central nervous system that causes inflammation, demyelinating lesions, and axonal damage and is associated with a high rate of early-onset disability. Disease-modifying therapies are used to mitigate the inflammatory proces...

Descripción completa

Detalles Bibliográficos
Autores principales:	López-Muguruza, Eneritz, Villar-Gómez, Natalia, Matias-Guiu, Jordi A., Selma-Calvo, Belen, Moreno-Jiménez, Lidia, Sancho-Bielsa, Francisco, Lopez-Carbonero, Juan, Benito-Martín, María Soledad, García-Flores, Silvia, Bonel-García, Natalia, Kamal, Ola Mohamed-Fathy, Ojeda-Hernández, Denise, Matías-Guiu, Jorge, Gómez-Pinedo, Ulises
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027199/ https://www.ncbi.nlm.nih.gov/pubmed/35454965 http://dx.doi.org/10.3390/life12040474

Ejemplares similares

Nose-to-Brain: The Next Step for Stem Cell and Biomaterial Therapy in Neurological Disorders
por: Villar-Gómez, Natalia, et al.
Publicado: (2022)

Vitamin D increases remyelination by promoting oligodendrocyte lineage differentiation
por: Gomez‐Pinedo, Ulises, et al.
Publicado: (2019)

Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis
por: Ojeda-Hernández, Doddy Denise, et al.
Publicado: (2022)

Experimental models of demyelination and remyelination()
por: Torre-Fuentes, L., et al.
Publicado: (2020)

Chitosan–Hydroxycinnamic Acids Conjugates: Emerging Biomaterials with Rising Applications in Biomedicine
por: Ojeda-Hernández, Doddy Denise, et al.
Publicado: (2022)

In Vitro Effects of Methylprednisolone over Oligodendroglial Cells: Foresight to Future Cell Therapies
por: Gómez-Pinedo, Ulises, et al.
Publicado: (2023)

Particles Containing Cells as a Strategy to Promote Remyelination in Patients With Multiple Sclerosis
por: Matías-Guiu, Jorge, et al.
Publicado: (2020)

Editorial: The Use of Biomaterials With Stem and Precursor Cells in Diseases of the Central Nervous System; A Step to Clinical Trials
por: Ramos-Zúñiga, Rodrigo, et al.
Publicado: (2021)

Sera from Patients with NMOSD Reduce the Differentiation Capacity of Precursor Cells in the Central Nervous System
por: Gómez-Pinedo, Ulises, et al.
Publicado: (2021)

Experimental Models for the Study of Central Nervous System Infection by SARS-CoV-2
por: Sanclemente-Alaman, Inmaculada, et al.
Publicado: (2020)

Immununochemical Markers of the Amyloid Cascade in the Hippocampus in Motor Neuron Diseases
por: Gómez-Pinedo, Ulises, et al.
Publicado: (2016)

Notch Signalling in the Hippocampus of Patients With Motor Neuron Disease
por: Gómez-Pinedo, Ulises, et al.
Publicado: (2019)

Intranasal Administration of Undifferentiated Oligodendrocyte Lineage Cells as a Potential Approach to Deliver Oligodendrocyte Precursor Cells into Brain
por: Gómez-Pinedo, Ulises, et al.
Publicado: (2021)

Amyotrophic lateral sclerosis modifies progenitor neural proliferation in adult classic neurogenic brain niches
por: Galán, Lucía, et al.
Publicado: (2017)

Editorial: COVID-19 in CNS and PNS: Basic and Clinical Focus on the Mechanisms of Infection and New Tools for the Therapeutic Approach
por: Matias-Guiu, Jorge, et al.
Publicado: (2022)

Variants of genes encoding TNF receptors and ligands and proteins regulating TNF activation in familial multiple sclerosis
por: Torre‐Fuentes, Laura, et al.
Publicado: (2020)

Potential of Chitosan and Its Derivatives for Biomedical Applications in the Central Nervous System
por: Ojeda-Hernández, Doddy Denise, et al.
Publicado: (2020)

Alexander Disease Mutations Produce Cells with Coexpression of Glial Fibrillary Acidic Protein and NG2 in Neurosphere Cultures and Inhibit Differentiation into Mature Oligodendrocytes
por: Gómez-Pinedo, Ulises, et al.
Publicado: (2017)

Exonic variants of genes related to the vitamin D signaling pathway in the families of familial multiple sclerosis using whole‐exome next generation sequencing
por: Pytel, Vanesa, et al.
Publicado: (2019)

Should we expect neurological symptoms in the SARS-CoV-2 epidemic?()
por: Matías-Guiu, J., et al.
Publicado: (2020)

¿Es esperable que haya cuadros neurológicos por la pandemia por SARS-CoV-2?
por: Matías-Guiu, J., et al.
Publicado: (2020)

Familial multiple sclerosis and association with other autoimmune diseases
por: Pytel, Vanesa, et al.
Publicado: (2017)

Modelos experimentales de desmielinización-remielinización
por: Torre-Fuentes, L., et al.
Publicado: (2020)

Management of neurological care during the COVID-19 pandemic()
por: Matías-Guiu, J., et al.
Publicado: (2020)

La gestión de la asistencia neurológica en tiempos de la pandemia de Covid-19
por: Matías-Guiu, J., et al.
Publicado: (2020)

Alterations of Oligodendrocyte and Myelin Energy Metabolism in Multiple Sclerosis
por: López-Muguruza, Eneritz, et al.
Publicado: (2023)

Validation of the European Cross-Cultural Neuropsychological Test Battery (CNTB) for the assessment of mild cognitive impairment due to Alzheimer's disease and Parkinson's disease
por: Delgado-Álvarez, Alfonso, et al.
Publicado: (2023)

Infection Mechanism of SARS-COV-2 and Its Implication on the Nervous System
por: Reza-Zaldívar, Edwin Estefan, et al.
Publicado: (2021)

Hippocampal subfield abnormalities and biomarkers of pathologic brain changes: from SARS-CoV-2 acute infection to post-COVID syndrome
por: Díez-Cirarda, Maria, et al.
Publicado: (2023)

Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain
por: Montero-Escribano, Paloma, et al.
Publicado: (2020)

The role of scientific journal editors during the COVID-19 pandemic()
por: Matias-Guiu, J.
Publicado: (2020)

Nuevos tiempos, nuevas prioridades
por: Matias-Guiu, Xavier
Publicado: (2020)

El papel del editor de una revista científica durante la pandemia del Covid-19
por: Matias-Guiu, J.
Publicado: (2020)

Predominance of visuoconstructive impairment after mild COVID-19?
por: Díez-Cirarda, María, et al.
Publicado: (2022)

Convivir con Alzheimer /
por: Matías-Guiu Guía, Jordi
Publicado: (2004)

Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab
por: Matías-Guiu, Jorge, et al.
Publicado: (2020)

Lipid Metabolic Alterations in the ALS–FTD Spectrum of Disorders
por: Godoy-Corchuelo, Juan Miguel, et al.
Publicado: (2022)

Relevance of pathologic features in risk stratification for early-stage endometrial cancer
por: Guerra, Esther, et al.
Publicado: (2021)

GA-MADRID: design and validation of a machine learning tool for the diagnosis of Alzheimer’s disease and frontotemporal dementia using genetic algorithms
por: García-Gutierrez, Fernando, et al.
Publicado: (2022)

An Online Observational Study of Patients With Olfactory and Gustory Alterations Secondary to SARS-CoV-2 Infection
por: Gómez-Iglesias, Patricia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eh7d0qofbcimbecv4c1h4lk92a